Literature DB >> 18928980

Maternal glucose levels after dexamethasone for fetal lung development in twin vs singleton pregnancies.

Lisa M Foglia1, Shad H Deering, Elaine Lim, Helain Landy.   

Abstract

OBJECTIVE: Betamethasone administration in singleton pregnancies causes maternal hyperglycemia. With the increased risk of glucose intolerance in twin pregnancies, we sought to determine whether maternal hyperglycemia after dexamethasone administration is different in twin vs singleton pregnancies. STUDY
DESIGN: Patients with singleton or twin pregnancies admitted between 24 and 34 weeks' gestation with diagnoses requiring steroid administration were approached. Exclusion criteria included diabetes, abnormal glucose tolerance test, infection, or medications known to interfere with glucose metabolism. Patients were NPO for 24 hours and received dexamethasone per protocol. Maternal glucose levels were checked at baseline and then at specified intervals after the initial dose; appropriate statistical analysis was performed.
RESULTS: Ten singleton and 9 twin gestations were enrolled. There were no differences in mean maternal or gestational ages. Mean glucose levels were significantly higher in the twin group at 4 hours (114 mg/dL vs 95.6 mg/dL), 8 hours (121.4 mg/dL vs 90.9 mg/dL), and 24 hours (116 mg/dL vs 81 mg/dL) (P < .01 for all).
CONCLUSION: Twin pregnancies had higher mean glucose values than singleton pregnancies in the first 24 hours after dexamethasone administration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18928980     DOI: 10.1016/j.ajog.2008.08.004

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Changes in maternal glucose metabolism after the administration of dexamethasone for fetal lung development.

Authors:  Xu Jian Yun; Liang Zhaoxia; Chai Yun; Fang Qin; Chen Yuanyuan; Chen Danqing
Journal:  Int J Endocrinol       Date:  2012-03-25       Impact factor: 3.257

2.  Judicious use of antenatal glucocorticoids: putting the risks into the balance.

Authors:  J Verhaeghe
Journal:  Facts Views Vis Obgyn       Date:  2011
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.